David R. Epstein - 10 Jun 2022 Form 4 Insider Report for Evelo Biosciences, Inc.

Role
Director
Signature
/s/ Daniel S. Char, Attorney-in-Fact for David R. Epstein
Issuer symbol
EVLO on OTC
Transactions as of
10 Jun 2022
Net transactions value
$0
Form type
4
Filing time
13 Jun 2022, 16:41:28 UTC
Previous filing
10 Jun 2022
Next filing
30 Jun 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction EVLO Stock Option (Right to Buy) Award $0 +20,000 $0.000000 20,000 10 Jun 2022 Common Stock 20,000 $2.02 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests on the earlier of June 10, 2023 and the day immediately prior to the date of the next annual meeting of the Issuer's stockholders occurring after the date of grant.